As P-tau and Aβ1–42 are established biomarkers for current and future cognitive performance in mild cognitive impairment and AD [21], findings from the current study accords with the study by Jakobsson and colleagues who found no evidence of an Alzheimer like CSF pattern in patients with bipolar disorder [16]. This evidence concerns the gene MAPT and bipolar disorder.